These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 14613446)

  • 1. Prescription drug expenditures, financial burden and health plan satisfaction among medicare beneficiaries.
    Curtiss FR
    J Manag Care Pharm; 2003; 9(5):453-4, 455-6. PubMed ID: 14613446
    [No Abstract]   [Full Text] [Related]  

  • 2. Medicare Part D: decision, decisions, decisions. Medicare prescription drug coverage should save many people some money, but it puts a new burden on beneficiaries to be smart shoppers.
    Harv Health Lett; 2005 Dec; 31(2):4-5. PubMed ID: 16440454
    [No Abstract]   [Full Text] [Related]  

  • 3. Out-of-pocket prescription costs a continuing burden under Medicare Part D.
    Am Fam Physician; 2006 Feb; 73(3):402. PubMed ID: 16477887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medicare Part D: who wins, who loses?
    Am Fam Physician; 2006 Feb; 73(3):401. PubMed ID: 16477886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mind the gap: Medicare Part D's coverage gaps may affect patient adherence.
    Am Fam Physician; 2006 Feb; 73(3):404. PubMed ID: 16477888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prescription drug prices in Canada.
    Gross D
    Issue Brief (Public Policy Inst (Am Assoc Retired Pers)); 2003 Jun; (IB62):1-22. PubMed ID: 12807123
    [No Abstract]   [Full Text] [Related]  

  • 7. Medicare Part D: practical and policy implications for family physicians.
    Mallya G; Bazemore A
    Am Fam Physician; 2006 Feb; 73(3):395-6. PubMed ID: 16477884
    [No Abstract]   [Full Text] [Related]  

  • 8. Insurance coverage for prescription drugs: effects on use and expenditures in the Medicare population.
    Lillard LA; Rogowski J; Kington R
    Med Care; 1999 Sep; 37(9):926-36. PubMed ID: 10493470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Managing the gap in medicare Part D's prescription coverage. Interview by Cheryl Thompson.
    Durley SF
    Am J Health Syst Pharm; 2006 Dec; 63(23):2319, 2323, 2326. PubMed ID: 17106004
    [No Abstract]   [Full Text] [Related]  

  • 10. State Medicaid prescription drug expenditures for Medicare-Medicaid dual eligibles: estimates of Medicaid savings and federal expenditures resulting from expanded Medicare prescription coverage.
    Dale SB; Verdier JM
    Issue Brief (Commonw Fund); 2003 Apr; (627):1-12. PubMed ID: 12685428
    [No Abstract]   [Full Text] [Related]  

  • 11. Prescription drug coverage and effects on drug expenditures among elderly Medicare beneficiaries.
    Huh S; Rice T; Ettner SL
    Health Serv Res; 2008 Jun; 43(3):810-32. PubMed ID: 18454769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of the coverage gap on drug spending: a closer look at Medicare Part D.
    Zhang Y; Donohue JM; Newhouse JP; Lave JR
    Health Aff (Millwood); 2009; 28(2):w317-25. PubMed ID: 19189991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prescription drug coverage for people with Medicare.
    Stein N
    Issue Brief Cent Medicare Educ; 2002; 3(9):1-8. PubMed ID: 12516561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The new Medicare Part D prescription drug benefit: an estimation of its effect on prescription drug costs in a Medicare population with atrial fibrillation.
    Evans-Molina C; Regan S; Henault LE; Hylek EM; Schwartz GR
    J Am Geriatr Soc; 2007 Jul; 55(7):1038-43. PubMed ID: 17608876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Falling into the doughnut hole: drug spending among beneficiaries with end-stage renal disease under Medicare Part D plans.
    Patel UD; Davis MM
    J Am Soc Nephrol; 2006 Sep; 17(9):2546-53. PubMed ID: 16855016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selected characteristics of senior citizens prescription drug payment and procurement in 1998 and 2001.
    Schommer JC; Mott DA; Hansen RA; Cline RR
    J Manag Care Pharm; 2003; 9(5):408-15. PubMed ID: 14613438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug coverage for Medicare beneficiaries: why protection may be in jeopardy.
    Briesacher B; Stuart B; Shea D
    Issue Brief (Commonw Fund); 2002 Jan; (505):1-8. PubMed ID: 11922051
    [No Abstract]   [Full Text] [Related]  

  • 18. Medicare risk programs and pharmacy benefits managers.
    Herzfeld J
    Med Interface; 1996 Dec; 9(12):75-8. PubMed ID: 10172875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medicare prescription drug plan costs and affordability--2007.
    Davis MM
    J Gen Intern Med; 2007 Aug; 22(8):1221-2. PubMed ID: 17497191
    [No Abstract]   [Full Text] [Related]  

  • 20. Estimating the effects of prescription drug coverage for Medicare beneficiaries.
    Shea DG; Terza JV; Stuart BC; Briesacher B
    Health Serv Res; 2007 Jun; 42(3 Pt 1):933-49. PubMed ID: 17489897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.